P923: TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATIONS STILL BENEFIT FOR MYELOMA PATIENTS: A POOLING META-ANALYSIS

P923: TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATIONS STILL BENEFIT FOR MYELOMA PATIENTS: A POOLING META-ANALYSIS

Bibliographic Details
Main Authors:	C.-H. Lee, C.-L. Ho
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846560.60635.7b

Similar Items

AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
by: Bergantim Rui, et al.
Published: (2012-11-01)

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis
by: Hongtao Li, et al.
Published: (2024-12-01)

Efficacy and safety of tandem autologous stem cell transplantation in multiple myeloma: a retrospective single-center analysis
by: Shunquan Wu, et al.
Published: (2023-08-01)

QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
by: Alhossain A. Khalafallah, et al.
Published: (2011-11-01)

Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis
by: Min Wei, et al.
Published: (2023-12-01)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
by: Simone A. Minnie, et al.
Published: (2021-03-01)

Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis
by: Chi-Maw Lin, et al.
Published: (2023-05-01)

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study
by: Michael Byrne, et al.
Published: (2014-09-01)

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study
by: Michael Byrne, et al.
Published: (2014-01-01)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
by: Lakshmi Yarlagadda, et al.
Published: (2021-08-01)

Multiple Myeloma: Front Line Therapy and Autologous Stem Cell Transplantation
by: Lalit Kumar
Published: (2018-04-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

P900: SALVAGE AUTOLOGOUS STEM CELL TRANSPLANT IN RELAPSED MULTIPLE MYELOMA: A SINGLE CENTRE EXPERIENCE
by: S. Duarte, et al.
Published: (2022-06-01)

Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
by: Chuanying Geng, et al.
Published: (2022-12-01)

Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry
by: Tzu-Chuan Huang, et al.
Published: (2019-01-01)

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation
by: Wancheng Guo, et al.
Published: (2024-03-01)

Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective
by: Doris K Hansen MD, et al.
Published: (2023-09-01)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
by: Malkan Umit Yavuz, et al.
Published: (2021-01-01)

Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma
by: Aina Oliver-Caldes, et al.
Published: (2022-07-01)

Autologous stem cell transplantation in the treatment of multiple myeloma single center experience
by: Marjanović Slobodan, et al.
Published: (2011-01-01)

Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
by: Felicetto Ferrara, et al.
Published: (2019-12-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
by: Anna Waszczuk-Gajda, et al.
Published: (2022-06-01)

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
by: Sarah A. Bird, et al.
Published: (2020-05-01)

Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy
by: Charlotte F. M. Hughes, et al.
Published: (2024-03-01)

Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma
by: Noa Biran, et al.
Published: (2021-08-01)

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
by: Alicia Bao, et al.
Published: (2023-07-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
by: Selami Koçak Toprak
Published: (2013-09-01)

Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
by: Green David L, et al.
Published: (2009-11-01)

Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis
by: Malgorzata Wach, et al.
Published: (2011-07-01)

Mobilization potential of patients with lymphomas and multiple myeloma involved in autologous stem cell transplant
by: Stančev Katarina, et al.
Published: (2020-01-01)

Double Autologous Stem Cell Transplantation in a Case of Non-secretory Multiple Myeloma
by: Lázár Erzsébet, et al.
Published: (2016-12-01)

AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: EXPERIENCE OF A PUBLIC CENTER IN BRAZIL
by: L Oliveira, et al.
Published: (2021-10-01)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
by: Hyunkyung Park, et al.
Published: (2020-07-01)

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
by: Marc-Andrea Baertsch, et al.
Published: (2021-01-01)

P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES
by: Oren Pasvolsky, et al.
Published: (2023-08-01)

P1303: DARATUMUMAB-BASED MAINTENANCE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AFTER SALVAGE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Oren Pasvolsky, et al.
Published: (2023-08-01)

Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation
by: Denise D. Correa, et al.
Published: (2023-09-01)